The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065749 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Abdelrahim Alqudah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental, Metformin, Insulin Resistance. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at The Hashemite University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Cirsimaritin is a dimethoxy flavon that has different biological activities such as antiproliferative, antimicrobial, and antioxidant activities. This study aims to investigate the anti-diabetic effects of cirsimaritin in a high-fat diet and streptozotocin-(HFD/STZ)-induced rat model of type 2 diabetes mellitus (T2D). Rats were fed HFD, followed by a single low dose of STZ (40 mg/kg). HFD/STZ diabetic rats were treated orally with cirsimaritin (50 mg/kg) or metformin (200 mg/kg) for 10 days before terminating the experiment and collecting plasma, soleus muscle, adipose tissue, and liver for further downstream analysis. Cirsimaritin reduced the elevated levels of serum glucose in diabetic rats compared to the vehicle control group (p < 0.001). Cirsimaritin abrogated the increase in serum insulin in the treated diabetic group compared to the vehicle control rats (p < 0.01). The homeostasis model assessment of insulin resistance (HOMA-IR) was decreased in the diabetic rats treated with cirsimaritin compared to the vehicle controls. The skeletal muscle and adipose tissue protein contents of GLUT4 (p < 0.01 and p < 0.05, respectively) and pAMPK-α1 (p < 0.05) were upregulated following treatment with cirsimaritin. Cirsimaritin was able to upregulate GLUT2 and AMPK protein expression in the liver (p < 0.01,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
- Department of Medical Laboratory Sciences, Faculty of Allied Science, Zarqa University, Zarqa 13110, Jordan.
- Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
- Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
- Prince Hamza Hospital, Amman 11123, Jordan.
ORCID-Profile: Abdelrahim Alqudah, Esam Qnais, Omar Gammoh, Mohammad Alqudah
Förderung
- Deanship of Scientific Research at The Hashemite University
Zitieren
APA
Alqudah, A., Athamneh, R. Y., Qnais, E., Gammoh, O., Oqal, M., AbuDalo, R., Alshaikh, H. A., Al-Hashimi, N., & Alqudah, M. (2023). The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065749
Vancouver
Alqudah A, Athamneh RY, Qnais E, Gammoh O, Oqal M, AbuDalo R, et al. The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065749
BibTeX
@article{Alqudah2023,
author = {Alqudah, Abdelrahim and Athamneh, Rabaa Y and Qnais, Esam and Gammoh, Omar and Oqal, Muna and AbuDalo, Rawan and Alshaikh, Hanan Abu and Al-Hashimi, Nabil and Alqudah, Mohammad},
title = {The Emerging Importance of Cirsimaritin in Type 2 Diabetes Treatment},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065749}
}
EUVIMED